Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,683 | -3,043 | -2,267 | -7,891 | -21,010 |
| Depreciation Amortization | 782 | 712 | 975 | 996 | 6,578 |
| Income taxes - deferred | 5 | 0 | -365 | 173 | 4,100 |
| Accounts receivable | 147 | 375 | 468 | 587 | -7 |
| Accounts payable and accrued liabilities | -122 | -454 | 286 | -857 | -1,500 |
| Other Working Capital | -278 | -561 | 528 | 566 | 4 |
| Other Operating Activity | 1,566 | 1,228 | 941 | 1,404 | 9,200 |
| Operating Cash Flow | $-2,584 | $-1,742 | $565 | $-5,022 | $-2,635 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 331 | 0 | N/A |
| PPE Investments | -77 | 3 | -211 | 43 | -255 |
| Net Acquisitions | 166 | N/A | N/A | 2,678 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | 170 | -59 |
| Other Investing Activity | -608 | 0 | -195 | 1,778 | 269 |
| Investing Cash Flow | $-518 | $3 | $-75 | $4,669 | $-45 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -431 | -22 | 224 | N/A | -229 |
| Debt Repayment | N/A | N/A | -197 | N/A | -200 |
| Common Stock Issued | 2,961 | 1,758 | 0 | N/A | 3,911 |
| Other Financing Activity | 370 | 0 | 0 | -626 | -67 |
| Financing Cash Flow | $2,900 | $1,736 | $28 | $-626 | $3,415 |
| Exchange Rate Effect | 0 | -35 | -16 | -41 | 5 |
| Beginning Cash Position | 1,027 | 1,064 | 563 | 1,583 | 843 |
| End Cash Position | 825 | 1,027 | 1,064 | 563 | 1,583 |
| Net Cash Flow | $-202 | $-38 | $502 | $-1,020 | $740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,584 | -1,742 | 565 | -5,022 | -2,635 |
| Capital Expenditure | -77 | -9 | -326 | -6 | -285 |
| Free Cash Flow | -2,660 | -1,751 | 239 | -5,028 | -2,920 |